Franck Zal

Franck Zal is the CEO and CSO of HEMARINA, a biotechnology company specializing in the development of oxygen carriers derived from marine worms for therapeutic applications related to ischemia and anemia, as well as industrial uses in bioproduction and stem cell research since March 2007. Prior to this role, Franck Zal worked as a group leader in Ecophysiology at CNRS UMR 7144 from October 1999 to March 2009, where responsibilities included leading research on adaptation and molecular evolution. Educational qualifications include an Executive MBA from Rennes School of Business, an Habilitation à Diriger des Recherches from Pierre and Marie Curie University, and multiple post-doctoral and doctoral degrees focused on biochemistry and marine ecophysiology from renowned universities.